טוען...
Levodopa in Parkinson’s Disease: Current Status and Future Developments
BACKGROUND: Ever since the pioneering reports in the 60s, L-3,4-Dioxyphenylalanine (levodopa) has represented the gold standard for the treatment of Parkinson’s Disease (PD). However, long-term levodopa (LD) treatment is frequently associated with fluctuations in motor response with serious impact o...
שמור ב:
| הוצא לאור ב: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bentham Science Publishers
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6187751/ https://ncbi.nlm.nih.gov/pubmed/28494719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X15666170510143821 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|